Neurocognitive testing for Parkinson's (NCT05025254)
Detect early cognitive decline Parkinsons
- Trial ID
- NCT05025254
- Official Title
- Deep Cognitive Endophenotyping of Parkinson's Disease: A Platform Development and Pilot Study
- Goal
- Detect early cognitive decline Parkinsons
- Status
- RECRUITING
- Sponsor
- McGill University
- Study Type
- OBSERVATIONAL
- Enrollment
- 1000 participants
- Conditions
- Parkinson Disease
- Interventions
- Neurocognitive testing
Summary For Families
The goal is to create a detailed cognitive fingerprint to better identify and track the thinking and memory changes that happen in Parkinson's, and to develop sensitive tools for future research or care. The approach is observational neurocognitive testing, using paper and computer tasks that measure memory, attention, language, and problem solving to detect subtle changes earlier than routine exams; it does not test a drug and does not change your Parkinson's medications. The study is looking for people aged 45 to 90 with Parkinson's diagnosed by a neurologist, plus healthy adults with no neurological illness as controls. People with psychotic spectrum disorders, uncontrolled depression, advanced dementia needing daily help, major stroke, major head injury, or epilepsy treated with anti-seizure medications are not eligible.
Locations
- McGill University Health Centre, Montreal, Quebec, Canada
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Neurocognitive testing. The goal is to create a detailed cognitive fingerprint to better identify and track the thinking and memory changes that happen in Parkinson's, and to develop sensitive tools for future research or care. The approach is observational neurocognitive testing, using paper and computer tasks that measure memory, attention, language, and problem solving to detect subtle changes earlier than routine exams; it does not test a drug and does not change your Parkinson's medications. The study is looking for people aged 45 to 90 with Parkinson's diagnosed by a neurologist, plus healthy adults with no neurological illness as controls. People with psychotic spectrum disorders, uncontrolled depression, advanced dementia needing daily help, major stroke, major head injury, or epilepsy treated with anti-seizure medications are not eligible.
- Who can participate?
- Participants must be between 45 Years and 90 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 1 month.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive); Thinking & memory tests (non-invasive). Confirm the full schedule with the study coordinator.